New biosimilar to blockbuster Neulasta available soon
Sandoz now has 2 biosimilars to the popular cancer drug.
Read more
 
Lung cancer drug receives breakthrough therapy designation
Targeted therapy gives new hope to patients with an aggressive form of lung cancer.
Read more
 
Accurate response assessments vital to cancer treatments
From our sister publication, Managed Healthcare Executive: Researchers are investigating new ways to evaluate responses to cancer treatment that could provide valuable information on finding the best methods to improve patient outcomes.
Read more